Immunosuppressant management upon elexacaftor/tezacaftor/ivacaftor initiation in cystic fibrosis patients with prior liver transplant

J Cyst Fibros. 2023 Nov 23:S1569-1993(23)01675-2. doi: 10.1016/j.jcf.2023.11.004. Online ahead of print.

Authors

Diana Coman¹, Catherine Vincent¹, Genevieve Huard¹, Denis Marleau¹, Annick Lavoie², Julian Hercun¹

Affiliations

¹ Liver Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.
² Respirology Unit - Centre hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada.

PMID: 38000917
DOI: 10.1016/j.jcf.2023.11.004

No abstract available

Keywords: CFTR modulators; Cystic fibrosis liver disease; Elexacaftor/tezacaftor/ivacaftor/; Liver transplant.

Publication types

Letter